Format

Send to

Choose Destination
Curr Psychiatry Rep. 2016 Jun;18(6):55. doi: 10.1007/s11920-016-0696-z.

Combining Pharmacological and Psychological Treatments for Binge Eating Disorder: Current Status, Limitations, and Future Directions.

Author information

1
Department of Psychiatry, School of Medicine, Yale University, New Haven, CT, USA. carlos.grilo@yale.edu.
2
Regional Department for Eating Disorders, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
3
Department of Psychology, Faculty of Social Sciences, University of Oslo, Oslo, Norway.
4
Neuropsychiatric Research Institute, Fargo, ND, USA.
5
Department of Clinical Neuroscience, School of Medicine and Health Sciences, University of North Dakota, Fargo, ND, USA.

Abstract

Binge eating disorder (BED) is characterized by recurrent binge eating and marked distress about binge eating without the extreme compensatory behaviors for weight control that characterize other eating disorders. BED is prevalent, associated strongly with obesity, and is associated with heightened levels of psychological, psychiatric, and medical concerns. This article provides an overview of randomized controlled treatments for combined psychological and pharmacological treatment of BED to inform current clinical practice and future treatment research. In contrast to the prevalence and significance of BED, to date, limited research has been performed on combining psychological and pharmacological treatments for BED to enhance outcomes. Our review here found that combining certain medications with cognitive behavioral therapy (CBT) or behavioral weight loss (BWL) interventions produces superior outcomes to pharmacotherapy only but does not substantially improve outcomes achieved with CBT/BWL only. One medication (orlistat) has improved weight losses with CBT/BWL albeit minimally, and only one medication (topiramate) has enhanced reductions achieved with CBT in both binge eating and weight. Implications for future research are discussed.

KEYWORDS:

Behavioral weight loss; Binge eating disorder; Cognitive behavioral therapy; Medication; Obesity; Pharmacotherapy

PMID:
27086316
DOI:
10.1007/s11920-016-0696-z
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center